bioAffinity Technologies, Inc. (BIAF)
9.82
-0.68
(-6.48%)
USD |
NASDAQ |
Sep 10, 12:27
bioAffinity Technologies Price : 9.82 for Sept. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 10.90 | 12.32 | 10.09 | 10.50 | 10.46M |
| Sep 08, 2026 | 10.63 | 10.63 | 8.36 | 8.93 | 2.412M |
| Sep 04, 2026 | 11.12 | 20.35 | 10.90 | 15.27 | 20.09M |
| Sep 03, 2026 | 13.20 | 13.58 | 11.06 | 12.78 | 19.25M |
| Sep 02, 2026 | 7.61 | 11.75 | 7.54 | 9.75 | 46.05M |
| Sep 01, 2026 | 7.72 | 8.60 | 6.13 | 6.59 | 46.39M |
| Aug 31, 2026 | 4.83 | 4.98 | 4.56 | 4.56 | 36149.00 |
| Aug 28, 2026 | 4.95 | 5.17 | 4.87 | 4.87 | 30377.00 |
| Aug 27, 2026 | 5.00 | 5.13 | 4.96 | 5.06 | 43404.00 |
| Aug 26, 2026 | 5.19 | 5.32 | 4.88 | 5.09 | 79679.00 |
| Aug 25, 2026 | 5.40 | 5.47 | 5.08 | 5.19 | 88773.00 |
| Aug 24, 2026 | 6.02 | 6.35 | 5.725 | 5.82 | 167438.0 |
| Aug 21, 2026 | 5.760 | 6.297 | 5.476 | 6.000 | 68444.00 |
| Aug 20, 2026 | 5.793 | 6.673 | 5.475 | 6.001 | 226059.0 |
| Aug 19, 2026 | 6.771 | 6.771 | 5.868 | 6.135 | 286474.0 |
| Aug 18, 2026 | 7.981 | 8.547 | 6.525 | 7.099 | 11.34M |
| Aug 17, 2026 | 6.225 | 6.300 | 5.775 | 5.880 | 22719.00 |
| Aug 14, 2026 | 5.850 | 6.205 | 5.782 | 6.031 | 33874.00 |
| Aug 13, 2026 | 6.795 | 6.900 | 4.878 | 5.745 | 56191.00 |
| Aug 12, 2026 | 7.350 | 7.350 | 7.050 | 7.090 | 3756.00 |
| Aug 11, 2026 | 7.411 | 7.497 | 6.859 | 7.290 | 13519.00 |
| Aug 10, 2026 | 7.500 | 7.800 | 7.350 | 7.350 | 35445.00 |
| Aug 07, 2026 | 7.950 | 7.957 | 7.605 | 7.650 | 35203.00 |
| Aug 06, 2026 | 7.920 | 7.950 | 7.696 | 7.945 | 14451.00 |
| Aug 05, 2026 | 8.400 | 8.847 | 7.695 | 7.947 | 18978.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 20.74 |
| Perspective Therapeutics, Inc. | 2.80 |
| MiMedx Group, Inc. | 4.525 |
| Veracyte, Inc. | 42.93 |
| ABVC BioPharma, Inc. | 0.9999 |
Price Related Metrics
| PS Ratio | 0.4239 |
| Price to Book Value | 1.178 |
| Earnings Yield | -1.05K% |
| Market Cap | 4.441M |